Small molecule inhibitor
Showing 1 - 25 of >10,000
Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation Trial in San Francisco (Niraparib, Irinotecan)
Not yet recruiting
- Metastatic Solid Tumor
- +4 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jan 12, 2023
Breast Cancer Trial in Guangzhou (Take probiotics)
Recruiting
- Breast Cancer
- Take probiotics
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Mar 6, 2023
Ovarian Tumors, BRCA1 Protein, BRCA2 Protein Trial in Worldwide (KU-0059436 (AZD2281)(PARP inhibitor))
Active, not recruiting
- Ovarian Neoplasms
- +2 more
- KU-0059436 (AZD2281)(PARP inhibitor)
-
Brussels, Belgium
- +4 more
Dec 19, 2022
AML Including AML de Novo and AML Secondary to MDS, DLBCL Trial (Birabresib Dose 20 mg)
Terminated
- AML Including AML de Novo and AML Secondary to MDS
- DLBCL
- Birabresib Dose 20 mg
- (no location specified)
Aug 23, 2022
Primary Sclerosing Cholangitis Trial in Phoenix, Tempe, Rochester (Vidofludimus calcium)
Completed
- Primary Sclerosing Cholangitis
- Vidofludimus calcium
-
Phoenix, Arizona
- +2 more
Oct 11, 2022
Cancer of Pancreas, Cancer of the Pancreas, Tumors, Pancreatic Trial in Boston, New York (Talabostat Mesylate)
Withdrawn
- Cancer of Pancreas
- +4 more
- Talabostat Mesylate
-
Boston, Massachusetts
- +1 more
Feb 8, 2022
Nasopharyngeal Cancer, Epstein-Barr Virus Related Carcinoma Trial in Stanford (VK-2019)
Recruiting
- Nasopharyngeal Cancer
- Epstein-Barr Virus Related Carcinoma
-
Stanford, CaliforniaStanford University
Mar 31, 2022
Carcinosarcoma, Ovarian Trial in Oklahoma City (Galunisertib, Paclitaxel, Carboplatin)
Active, not recruiting
- Carcinosarcoma, Ovarian
- Galunisertib
- +2 more
-
Oklahoma City, OklahomaStephenson Cancer Center, University of Oklahoma Health Sciences
Sep 27, 2021
NUT Midline Carcinoma (NMC), Triple Negative Breast Cancer (TNBC), NSCLC (NSCLC) Trial (Birabresib)
Terminated
- NUT Midline Carcinoma (NMC)
- +3 more
- (no location specified)
Jan 7, 2021
Nutrition, Healthy Trial in Re?ovot (nutritional)
Recruiting
- Nutrition, Healthy
- nutritional
-
Reẖovot, IsraelWeizmann Institute of Science
Jul 16, 2023
Exploratory Drug Interaction Study Between SMIs and DOACs
Recruiting
- Solid Tumor
- Cancer, Lung
-
Nijmegen, Gelderland, Netherlands
- +1 more
Feb 7, 2023
Neurodegenerative Diseases Trial (SMARTO ONE, )
Not yet recruiting
- Neurodegenerative Diseases
- SMARTO ONE
- placebo
- (no location specified)
Jul 14, 2023
Neurodegenerative Diseases Trial (SMARTO ONE)
Not yet recruiting
- Neurodegenerative Diseases
- SMARTO ONE
- (no location specified)
Jul 14, 2023
Retinitis Pigmentosa Trial (KIO-301)
Recruiting
- Retinitis Pigmentosa
-
Adelaide, South Australia, AustraliaRoyal Adeliade Hospital
Dec 22, 2022
Small Molecule LCDM and GV Oocyte
Not yet recruiting
- Assisted Reproduction
- Small molecule LCDM
- (no location specified)
Apr 26, 2022
Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104)
Completed
- Clear Cell Renal Cell Carcinoma
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Feb 6, 2023
Biologics or Small Molecule Therapies in Inflammatory Bowel
Completed
- Crohn's Disease
- Ulcerative Colitis
-
New York, New York
- +1 more
Jan 9, 2023
Advanced Solid Tumor, Refractory Tumor Trial in Suzhou (Radiotherapy, PD-1/PD-L1 inhibitor, Granulocyte-macrophage
Recruiting
- Advanced Solid Tumor
- Refractory Tumor
- Radiotherapy
- +4 more
-
Suzhou, ChinaThe Second Affiliated Hospital of SchoowUniversity
Sep 14, 2023
Hepatocellular Carcinoma Trial (TACE(transcatheter arterial chemoembolization), lenvatinib, Icaritin soft capsules)
Not yet recruiting
- Hepatocellular Carcinoma
- TACE(transcatheter arterial chemoembolization)
- +2 more
- (no location specified)
Jun 5, 2023